- Home
- DTM vs BMRN Comparison
DTM vs BMRN Comparison
Compare DTM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTM
- BMRN
- Stock Information
- Founded
- DTM 2021
- BMRN 1996
- Country
- DTM United States
- BMRN United States
- Employees
- DTM N/A
- BMRN N/A
- Industry
- DTM Oil & Gas Production
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- DTM Utilities
- BMRN Health Care
- Exchange
- DTM Nasdaq
- BMRN Nasdaq
- Market Cap
- DTM 10.8B
- BMRN 11.3B
- IPO Year
- DTM N/A
- BMRN 1999
- Fundamental
- Price
- DTM $104.35
- BMRN $56.49
- Analyst Decision
- DTM Buy
- BMRN Buy
- Analyst Count
- DTM 11
- BMRN 23
- Target Price
- DTM $109.27
- BMRN $93.14
- AVG Volume (30 Days)
- DTM 770.9K
- BMRN 2.3M
- Earning Date
- DTM 07-31-2025
- BMRN 08-04-2025
- Dividend Yield
- DTM 3.15%
- BMRN N/A
- EPS Growth
- DTM N/A
- BMRN 154.69
- EPS
- DTM 3.74
- BMRN 3.40
- Revenue
- DTM $1,109,000,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- DTM $24.97
- BMRN $12.34
- Revenue Next Year
- DTM $7.91
- BMRN $10.01
- P/E Ratio
- DTM $27.86
- BMRN $17.50
- Revenue Growth
- DTM 15.28
- BMRN 18.36
- 52 Week Low
- DTM $71.97
- BMRN $52.93
- 52 Week High
- DTM $114.50
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- DTM 55.13
- BMRN 51.56
- Support Level
- DTM $101.26
- BMRN $58.92
- Resistance Level
- DTM $105.35
- BMRN $63.97
- Average True Range (ATR)
- DTM 2.47
- BMRN 1.82
- MACD
- DTM 0.50
- BMRN 0.06
- Stochastic Oscillator
- DTM 72.01
- BMRN 33.42
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.